Detroit Suboxone Doctors


Join Here To Have Your Medical Practice Featured in this space
and in the Google Map located below

Following payment completion, please send us the listing information you would like displayed here.

methadone8c



Detroit offers a variety of treatment alternatives for people struggling with a chronic opioid addiction. Prescription opiates have become a considerable problem with more people now addicted to them than heroin. With the escalation in opioid addiction over the past decade, methadone and suboxone have become increasingly important as treatment interventions to help those dealing with opiate withdrawal symptoms. Detroit has a substantial list of approved physicians authorized to write prescriptions for suboxone. Buprenorphine is the ingredient in suboxone that eliminates withdrawal. Suboxone is now more popular and is widely available across the U.S. based on its positive track record in alleviating opioid withdrawal. If you are a local physician aiming to treat Detroit residents, you may purchase a featured listing at the top of this page insuring that your medical services will be found by prospective patients searching our website for quality opioid treatment.



Detroit Buprenorphine Suboxone Doctors
Theadia L. Carey, M.D. Development Centers, Inc
24424 West McNichols
Detriot, MI 48219
(313) 255-0900
Renato Roxas, Jr. 50 East Canfield
Detroit, MI 48201
(313) 993-7489
Serge E. Jean-Louis Jabez Recovery Management Services, INC
835 Holden
Detroit, MI 48202
(313) 399-2563
Catherine Bernice Frank, M.D. Henry Ford Health System
One Ford Place 1F
Detroit, MI 48202
(313) 874-6677
Sudhir V. Lingnurkar, M.D. 3011 West Gerand Boulevard
Suite 1710
Detroit, MI 48202
(313) 872-6336
Maimoona Husain, M.D. 17950 Woodward Road
Detroit, MI 48203
(313) 867-2300
Serge E. Jean-Louis New Light Recovery Center, INC.
300 West. mcnichols
Detroit, MI 48203
(313) 867-8015
Asok Kumar Ray, M.D. 17950 Woodward Avenue
Detroit, MI 48203
(313) 867-2300
Vasan Deshikachar, M.D. 11803 Grand River Ave
Detroit, MI 48204
(313) 491-5544
Isidro C. Almeda, M.D. 15000 Gratiot Avenue
Suite 200
Detroit, MI 48205
(313) 579-8888
Carl Fowler, M.D. Northwest Industrial and Drug Rehab Clnc
9600 Dexter
Detroit, MI 48206
(313) 894-7881
Someswara N. Navuluri, M.D. 6309 Mack Avenue
Detroit, MI 48207
(313) 921-4700
Susan M Stine, M.D. 2761 East Jefferson Ave
Detroit, MI 48207
(313) 993-9879
Abdul Hafeez, M.D. Quality Behavioral Health, Inc
751 East Grand Boulevard
Detroit, MI 48207
(313) 922-2222
Oscar A. Apoian, D.O. 8633 West Vernor Highway
Detroit, MI 48209
(313) 841-7265
Sai Wentum, M.D. 4821 East McNichols Road
Detroit, MI 48212
(313) 368-4600
Isidro C. Almeda, M.D. 13929 Harper
Detroit, MI 48213
(313) 371-0055
Stanley M. Poleck, D.O. 19335 Grand River
Detroit, MI 48223
(313) 794-8780
Kenneth A. Brown, M.D. STAR Center, Inc.
13575 Lesure
Detroit, MI 48227
(313) 493-4410
Firas Zouabi, M.D. 18250 West Warren
Detroit, MI 48228
(313) 271-2800
Ashok Shantaram Karnik, M.D. 19953 Conant Street
Detroit, MI 48234
(313) 366-1115
Alphonse Ake-Ngole Ekole, M.D. COTTAB Medical Group @ Samaritan Ctr.
5555 Conner Suite 1223
Detroit, MI 48234
(313) 922-8843
Ernest Ameen Mullen, M.D. 19431 Vandyke
Detroit, MI 48234
(313) 893-2010
Richard T. Robinson, M.D. 4777 East Outer Drive
Detroit, MI 48234
(313) 369-5700
Otis L. Crawford, D.O. 18228 Steel
Detroit, MI 48235
(248) 547-2223
Kevin Carr Kyle, M.D. Kyle Medical
15101 West McNichols Road
Detroit, MI 48235
(313) 838-4600
Kamal Ibrahim, M.D. 6001 West Outer Drive
Unit 320
Detroit, MI 48235
(313) 397-1907
Rickie Hardaway, M.D. 15865 Wyoming
Detroit, MI 48238
(313) 342-2576


Helping Skeptics Understand Methadone

When it comes to addiction, reactions and opinions are often intense. Addiction is a devastating illness that can rapidly derail a person’s life, and seriously impact the lives of those around them.

Sadly, addiction leads people to behave in ways that make no sense to their family, friends, and co-workers. Therein lies an important part of the problem. Family feel confused, angry, and fearful as their loved one tumbles down the hill of active addiction.

When it comes to something as perplexing as drug addiction, grasping for answers is an understandable reflex for family and friends. What family often don’t comprehend is the power of physical dependency to opioids and the severe sickness that results from opioid withdrawal.

Family and others incorrectly assume that mere “choice” is all that’s needed to overcome the addiction. When the addict fails to remain drug free, harsh judgment by others usually follows.

Halting withdrawal sickness is a paramount step for an opioid addicted person. This cannot be overstated. As long as a person is suffering from severe opioid withdrawal, their ability to think and “choose” logically is greatly impaired.

Statistically, individuals who utilize medication-assisted treatment (like methadone) are far more likely to avoid incarceration, a continued downward spiral, or death by overdose. Medication assistance successfully removes debilitating withdrawal sickness so that the addicted person can experience greater clarity of thought and the ability to make more sound decisions that lead to improved quality of life.

If you are a skeptic about methadone or suboxone, you may think “they’re just trading one drug for another”. This is not true. People, once therapeutically stabilized on methadone or suboxone, do not get high from the medication. Health generally improves, and the person is able to function much better on the job and at home. This brings hope. It offers a new opportunity for further recovery.

When you care about a person’s survival, one more chance to help them can be quite valuable. Don’t let judgment or excessive skepticism get in the way. Medication-assistance in opioid recovery is effective for many people, and it has been the life saving next step that some never got the chance to take.

Posted in Methadone, Methadone Benefits, Methadone Clinics, Recovery, Suboxone | Tagged | Comments Off on Helping Skeptics Understand Methadone

Methadone Treatment in Oregon

Like most states, Oregon is in need of quality treatment options for opioid-addicted individuals who are ready for recovery.

This article, in the Hillsboro News-Times, features the recent approval by Washington County commissioners to add a new methadone clinic in Hillsboro, Oregon.

Acadia Healthcare is aiming to establish the new methadone clinic in Hillsboro in order to better serve the local community. Acadia already operate a mobile unit in the general area as well as a comprehensive treatment center (CTC) in nearby Tigard located about 20 miles away.

The commissioners voted 5-0 to approve the proposed site which will be on the local bus route thereby providing improved access. The article mentions that Oregon presently has 17 operational methadone clinics serving the state, where fentanyl, opiates, and other substances are causing a grave overdose crisis.

Having local opioid treatment available is a critically important step in saving lives and providing hope to patients and families. Methadone has been proven to decrease opioid use, reduce relapse risks & overdose deaths, as well as increase employment and overall health. Clinics offering medication-assisted treatment (MAT), like methadone and buprenorphine, are forging a new path to safety for those people once stuck in active addiction.

Posted in Acadia Healthcare, Addiction Treatment, Buprenorphine, Methadone, Methadone Clinics, Oregon Methadone Clinics, Suboxone | Tagged , , | Comments Off on Methadone Treatment in Oregon

Remote Observation of Methadone Dosing

There’s a new spin being proposed on the dispensing of methadone to Opioid Use Disorder (OUD) patients. A federally-funded project is underway between Scene Health and The University of Washington in which patients video themselves taking their daily methadone dose, and then submit that video to the treatment provider.

The project is evaluating this new modified approach that falls somewhere between in-person daily dosing and unsupervised take home dosing.

This new approach is currently being referred to as Video DOT (video direct observation therapy) and has been successfully implemented with other health issues including hepatitis C, asthma, and diabetes.

While this experiment seems appealing at first glance, it does raise legitimate questions about the ability to insure proper safety protocols with the provision of methadone medication to new patients. The project may possibly demonstrate the usefulness of Video DOT methadone dosing. But assuming this new approach one day becomes common practice, it will be important that physicians or clinics have in place a procedure for quickly reclaiming methadone doses that are not ingested on schedule.

Imagine a new patient receives 7 take home doses of methadone, but then only sends in the required video of their medication use on day one. At what point does the prescribing clinic intervene, and how will the unaccounted for doses be retrieved?

Approved Opioid Treatment Programs currently have “callback” procedures in which stable patients are randomly selected to return to their home clinic with their unused take home doses. This allows the clinic medical staff to perform a medication count, and it acts as a safeguard to insure patients are taking their medication as prescribed.

Patients who have earned take home privileges through months of treatment progress are less inclined to divert or misuse methadone than someone who just started treatment. New patients must be inducted gradually on a stabilizing dose of methadone. And time is typically needed to help these patients adjust to methadone while eliminating use of all other illicit substances. This is where the benefit of a structured treatment program is most relevant. OTP’s provide extremely valuable life management skills training in conjunction with medication therapy.

It remains to be seen if “easy access” to methadone is truly an advancement in care, or a step backwards in accountability & safety for patients and the public.

Posted in Medication Assisted Treatment, Methadone, Methadone Clinics, Methadone Programs, Suboxone, Suboxone Clinics | Tagged | Comments Off on Remote Observation of Methadone Dosing

Expanding Access to Methadone

Historically, access to methadone for the treatment of opioid addiction has been through enrollment in a local clinic licensed to dispense methadone. As a result of Covid restrictions, some of these clinic regulations were relaxed. For example, many patients across the U.S. were allowed to begin receiving take home doses of methadone as a result of Covid lockdowns and decreased clinic access.

Critics have begun to express the belief that clinic restrictions are cumbersome and that methadone should be made available for pick-up at local pharmacies. On the other hand, the concern remains that methadone can be misdirected or mishandled thus reinforcing the need for close supervision, particularly in the early phases of opioid treatment. Decades of research has shown that taken under proper supervision, methadone’s safety profile is excellent.

In this recent era of contaminated street opiates and overdose concerns, it is clear that methadone is a phenomenally effective medication for promoting health, well-being, and physical safety.

Mark Parrino, president of the American Association for the Treatment of Opioid Dependence, recently shared that deregulation of methadone would likely increase the diversion of methadone and methadone-related overdose deaths.

Following a period of stability, most U.S. clinics do allow patients to begin dosing at home with methadone. This system of care is working well throughout the country where methadone is readily available. However, many U.S. citizens are still lengthy distances from methadone-approved clinics. So, the challenge continues to link those with opioid addiction to effective resources in their local community. Legislators are presently examining a range of options as the opioid epidemic marches on.

Posted in Acadia Healthcare, Addiction Treatment, Brightview, Methadone, Methadone Clinics, Opioid Treatment, Suboxone | Tagged | Comments Off on Expanding Access to Methadone